Therakos, a Johnson & Johnson company, has struck a licensing deal with Argos Therapeutics. Therakos gains Arros' technology related to part of the immune system known as regulatory T cells. Financial details were not disclosed. Release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-argos-therapeutics-and-therakos-inc-enter-exclusive-agreement-regulator